BMN Blog

SEP 16

Nasal obstruction is a significant source of decreased productivity, decreased quality of life, and disruption in overall sleep and restfulness. There are many possible causes of nasal obstruction, including allergies, viral upper respiratory infections, nasal/sinus infections, or even very rarely sinonasal malignancies. Primarily, nasal obstruction is a factor of three sites that work together within the nose to create resistance to nasal airflow.

Read More
 
AUG 28

Obstructive Sleep Apnea (OSA) is a common problem affecting nearly one-third of the adult population. The long-term health effects of untreated OSA are beginning to become established and are frightening: increased risk of cardiovascular disease, stroke, dementia, pulmonary hypertension.

Read More
 
DEC 07
Awareness is everything when it comes to participating in a clinical trial. By Will O’Donnell – Research & Development Assistant, Clinical Research Center of Alabama in Clinical

Healthcare professionals are all well aware of what a clinical trial is, how they work, and the possibilities   that are provided to those who participate. However, the majority of Americans have not participated or heard about opportunities to participate in clinical research. According to a survey conducted by Research!America in partnership with Zogby Analytics (2017), fewer than 10% of Americans actually participate in clinical trials. Digging further into the reasons why, 55% of those surveyed stated that they were not aware or lacked information regarding clinical trials (Research!America, 2017).  

Read More
 
OCT 23
Pediatric Obstructive Sleep Apnea By Michael J. Latshaw, MD with Medical West Otolaryngology in Clinical

Sleep is a very important activity, that we often take for granted. It is especially important in children as it allows for proper neurological development. One disorder that is more and more common is sleep apnea, or interrupted sleep from breathing issues. We generally associate sleep apnea and distressed breathing while sleeping with adults, but it does occur with children - actually in 3-5% of children.

Read More
 
SEP 21
Advancements in Asthma, Atopic Dermatitis and Urticaria Treatment through Biologics By John Anderson, MD Board Certified Allergist/Immunologist at Alabama Allergy & Asthma Center and Research Director of the Clinical Research Center of Alabama in Clinical

Treatment options for asthma and other atopic conditions continue to evolve. In regard to asthma treatment, we primarily use inhaled corticosteroids and bronchodilators, we treat flares with steroids, and we offer allergy shots to patients with allergy triggers. Yet a significant proportion of patients remain poorly controlled and susceptible to morbidity from their asthma and the toll steroids take upon them.

Read More
 
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: